JP2018518151A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018518151A5 JP2018518151A5 JP2017550485A JP2017550485A JP2018518151A5 JP 2018518151 A5 JP2018518151 A5 JP 2018518151A5 JP 2017550485 A JP2017550485 A JP 2017550485A JP 2017550485 A JP2017550485 A JP 2017550485A JP 2018518151 A5 JP2018518151 A5 JP 2018518151A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- acid sequence
- isolated
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562139592P | 2015-03-27 | 2015-03-27 | |
| US62/139,592 | 2015-03-27 | ||
| PCT/US2016/024357 WO2016160620A2 (en) | 2015-03-27 | 2016-03-25 | Car t-cells for the treatment of b7-h4 expressing solid tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018518151A JP2018518151A (ja) | 2018-07-12 |
| JP2018518151A5 true JP2018518151A5 (enExample) | 2019-05-09 |
Family
ID=57007182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017550485A Withdrawn JP2018518151A (ja) | 2015-03-27 | 2016-03-25 | Ｂ７−ｈ４発現充実性腫瘍を処置するためのｃａｒ ｔ細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20180118831A1 (enExample) |
| EP (1) | EP3274369A4 (enExample) |
| JP (1) | JP2018518151A (enExample) |
| CN (1) | CN107531782A (enExample) |
| AU (1) | AU2016243126A1 (enExample) |
| CA (1) | CA2981143A1 (enExample) |
| IL (1) | IL254700A0 (enExample) |
| WO (1) | WO2016160620A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10814011B1 (en) | 2017-06-16 | 2020-10-27 | Nantbio, Inc. | Anti-B7-H4 antibodies and methods |
| CA3067914A1 (en) | 2017-06-30 | 2019-01-03 | Cellectis | Cellular immunotherapy for repetitive administration |
| US11306144B2 (en) | 2017-08-25 | 2022-04-19 | Five Prime Therapeutics, Inc. | B7-H4 antibodies and methods of use thereof |
| CN107903326B (zh) * | 2018-01-02 | 2020-06-30 | 广东省人民医院(广东省医学科学院) | 包含C3aR胞内结构域的嵌合抗原受体、慢病毒载体、表达细胞及药物 |
| CN116693686A (zh) * | 2018-02-11 | 2023-09-05 | 江苏豪森药业集团有限公司 | 抗b7-h4抗体、其抗原结合片段及其医药用途 |
| BR112020016986A2 (pt) | 2018-02-21 | 2021-03-02 | Five Prime Therapeutics, Inc. | formulações de anticorpo contra b7-h4 |
| KR20200144094A (ko) | 2018-03-02 | 2020-12-28 | 파이브 프라임 테라퓨틱스, 인크. | B7-h4 항체 및 이의 사용 방법 |
| KR102716165B1 (ko) * | 2019-03-21 | 2024-10-15 | 쑤저우 카노바 바이오파마슈티컬 컴퍼니 리미티드 | 항-b7s1 폴리펩티드 및 이의 용도 |
| IL283568B2 (en) * | 2019-08-01 | 2025-01-01 | Immunitybio Inc | NK–92 cells modified with a chimeric antigen receptor against B7–H4 |
| WO2021231959A1 (en) * | 2020-05-15 | 2021-11-18 | Precision Biosciences, Inc. | Methods for immunotherapy |
| AR124414A1 (es) | 2020-12-18 | 2023-03-22 | Century Therapeutics Inc | Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable |
| CN113156120B (zh) * | 2021-03-26 | 2022-03-25 | 中国医学科学院北京协和医院 | B7h4在制备子宫内膜癌分子分型试剂及系统中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6468546B1 (en) * | 1998-12-17 | 2002-10-22 | Corixa Corporation | Compositions and methods for therapy and diagnosis of ovarian cancer |
| US7811563B2 (en) * | 2004-10-25 | 2010-10-12 | Northwestern University | Anti-addl antibodies and uses thereof |
| US7858752B2 (en) * | 2006-12-05 | 2010-12-28 | Abbott Laboratories | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
| US8673314B2 (en) * | 2009-05-26 | 2014-03-18 | Mount Sinai School Of Medicine | Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
| US9422351B2 (en) * | 2011-11-03 | 2016-08-23 | The Trustees Of The University Of Pennsylvania | Isolated B7-H4 specific compositions and methods of use thereof |
| US9376485B2 (en) * | 2012-02-29 | 2016-06-28 | The Brigham And Women's Hospital, Inc. | Neutralizing antibody for epstein barr virus-associated disease |
| CA2887129A1 (en) * | 2012-10-09 | 2014-04-17 | Igenica, Inc. | Anti-c16orf54 antibodies and methods of use thereof |
| CA2894879A1 (en) * | 2012-12-19 | 2014-06-26 | Amplimmune, Inc. | B7-h4 specific antibodies, and compositions and methods of use thereof |
| JP6436965B2 (ja) * | 2013-03-14 | 2018-12-12 | ジェネンテック， インコーポレイテッド | 抗ｂ７−ｈ４抗体及びイムノコンジュゲート |
| EP3037819A4 (en) * | 2013-08-23 | 2017-03-29 | Fujita Health University | Method of determining resistance to influenza virus |
-
2016
- 2016-03-25 AU AU2016243126A patent/AU2016243126A1/en not_active Abandoned
- 2016-03-25 CN CN201680024423.4A patent/CN107531782A/zh active Pending
- 2016-03-25 JP JP2017550485A patent/JP2018518151A/ja not_active Withdrawn
- 2016-03-25 US US15/561,968 patent/US20180118831A1/en not_active Abandoned
- 2016-03-25 CA CA2981143A patent/CA2981143A1/en not_active Abandoned
- 2016-03-25 WO PCT/US2016/024357 patent/WO2016160620A2/en not_active Ceased
- 2016-03-25 EP EP16773873.1A patent/EP3274369A4/en not_active Withdrawn
-
2017
- 2017-09-26 IL IL254700A patent/IL254700A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018511319A5 (enExample) | ||
| JP2018518151A5 (enExample) | ||
| CN109843927B (zh) | 抗b7-h3抗体、其抗原结合片段及其医药用途 | |
| KR102924006B1 (ko) | 항-pd-l1/항-4-1bb 이중특이적 항체 및 이의 용도 | |
| Fisher et al. | Generation and preclinical characterization of an antibody specific for SEMA4D | |
| TWI878541B (zh) | 抗ｃｌｄｎ１８.２抗體及其診斷用途 | |
| CN112189021A (zh) | 抗b7-h3抗体及其用途 | |
| JP2018524973A5 (enExample) | ||
| JP2012012402A5 (enExample) | ||
| JP2018518152A5 (enExample) | ||
| CN111995682B (zh) | 抗人SIRPα单克隆抗体及其用途 | |
| JP2013506428A5 (enExample) | ||
| JP2014527398A5 (enExample) | ||
| CN113683697B (zh) | 抗b7-h3抗体、其制备方法及用途 | |
| KR20190034236A (ko) | 항 b7-h4 항체 | |
| JP2018505681A5 (enExample) | ||
| JP2022548777A5 (enExample) | ||
| JP2020513769A (ja) | 抗ｌａｉｒ１抗体およびその使用 | |
| WO2021097800A1 (en) | Anti-pd-l1/anti-b7-h3 multispecific antibodies and uses thereof | |
| WO2014068300A1 (en) | Anti-s100a4 antibody molecules and their uses | |
| CN111620949A (zh) | 结合人lag-3的抗体、其制备方法和用途 | |
| CN115298543A (zh) | 抗原抗体特异性结合识别方法 | |
| WO2018162944A1 (en) | Recombinant antibodies to programmed death 1 (pd-1) and uses therefor | |
| JPWO2014192974A1 (ja) | 抗ｌｇｒ６抗体を含む癌の検出用又は診断用試薬 | |
| JP7082112B2 (ja) | 抗ｇｐｒ２０抗体 |